Developer docs
API playgroundTry for free, no card

Search company profiles

People Science

Full company profile

uuid00029km

Namestring
People Science
Legal namestring
PEOPLE SCIENCE, INC.
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized clinical trials, clinical research platform, nutraceutical research, wearable health data, alternative medicine trials
Industry3 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers5132
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Decentralized Clinical Trial Platform
Social media profiles1 record
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Chloe Clinical SaaS subscriptions
TypeSubscription Recurring
Description

Software-as-a-Service licensing of the Chloe Clinical platform to enterprise customers (e.g., Persephone Biosciences). Recurring SaaS revenue from customers using Chloe as the sole software vendor for their decentralized clinical trials.

peoplescience.health
2Clinical Research Services (full-service / professional services)
TypeProfessional Services
Description

Fee-for-service clinical research support including principal investigators, protocol design/consultation, data analysis, manuscript preparation and submission, study project management, participant coordination, IRB/ethics board management, vendor management (labs, test kits, wearables), rapid participant recruitment, and inventory/shipping logistics. Engagements appear to be project-based contracts for individual studies.

peoplescience.health
3Chloe LiveLab collaborative research partnerships
TypeManaged Services
Description

Collaborative ingredient-brand research model with ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. Revenue model is partnership-driven, enabling joint promotional and evidence-generation activities (e.g., Phynova's Reducose® activation).

peoplescience.health
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Chloe Clinical SaaS — quote-based subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Software-as-a-Service model; pricing not publicly disclosed; positioned as affordable vs alternatives like REDCap.

peoplescience.health
2Full-service Clinical Research Services — custom project-based
ModelOtherBilling cadenceMulti-year contract
Notes

Per-study professional services pricing (protocol design, recruitment, coordination, data analysis, manuscript preparation); not publicly disclosed; consultative sales via "Schedule a Consultation."

peoplescience.health
3Chloe Consumer Health app for participants — free
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free to consumers/participants enrolling in studies; no subscription fee to participants.

peoplescience.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Chloe Clinical
Description

A decentralized clinical trial software-as-a-service platform that supports protocol-driven research with a customizable mobile app, wearables integration, bio-specimen collection, and HIPAA-compliant infrastructure.

peoplescience.health
+2 more records
Core offering1 text field

People Science operates a proprietary technology platform called CHLOE (Consumer Health Learning & Organizing Ecosystem) that powers decentralized clinical trials for consumer health, dietary supplement, cannabis, microbiome, and women's health brands. The offering combines a participant-facing mobile app, a researcher/admin web portal, and a clinical operations SaaS backend with integrated wearables, home biomarker collection, and HIPAA/GDPR-compliant data handling. The company wraps this software stack with optional full-service clinical research services (principal investigators, protocol design, IRB management, recruitment, data analysis, manuscript preparation), so customers can buy SaaS-only self-build, full-service execution, or a hybrid — evidenced by named engagements with Persephone Biosciences (SaaS-only ARTEMIS trial), Mimio, Verb Biotics, Life Extension, Phylos, Saalt, and Sip2Sleep.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

People Science offers a unified clinical research platform — the CHLOE (Consumer Health Learning & Organizing Ecosystem) — delivered as a portfolio of coordinated modules rather than a single monolithic product. At the core sits Chloe Clinical, the decentralized clinical trial SaaS used to design and run protocol-driven research at scale with fully customizable forms, e-consent, wearables integration, and bio specimen collection. Layered on top is Chloe LiveLab, a collaborative ingredient-brand research model that turns randomized controlled trial designs into consumer-facing real-world evidence experiences. The participant-facing Chloe App ties the platform together, enabling enrollment, data entry, wearable sync, and results delivery. People Science also wraps these software modules with Clinical Research Services covering protocol design, IRB management, recruitment, data analysis, and manuscript preparation, so clients can engage at any level from SaaS-only self-build (as Persephone Biosciences did for the ARTEMIS trial) through full-service execution.

Product and service4 records
1Chloe Clinical
CategoryDecentralized Clinical Trial SaaS
Description

A decentralized clinical trial software-as-a-service platform that enables protocol-driven research at any scale. Fully customizable, with high-quality data collection from an engaging participant mobile app, objective data collection through wearables integration (Oura, Garmin, Fitbit, Apple Watch, CGMs, smart scales) and bio specimen collections (blood, saliva, stool, urine, vaginal swabs), and HIPAA-compliant enterprise-grade security. Used by biotech sponsors (e.g., Persephone Biosciences ran the ARTEMIS infant synbiotic trial on it as sole software vendor) and supplement/cannabis brands for RCTs.

2Chloe LiveLab
CategoryReal-World Evidence Research Module
Description

A collaborative ingredient-brand research model that collects real-world health data from customers to bolster product claims, enhance participant engagement, identify super-users, and strengthen evidence with objective and subjective data from photos, wearables, and surveys. Targets ingredient suppliers and consumer brands seeking real-world evidence for functional ingredients.

3Clinical Research Services
CategoryProfessional Clinical Research Services
Description

Full-service research support offered alongside the Chloe platform: Scientific & Decentralized Trial Expertise (Principal Investigators, protocol design or consultation, data analysis, manuscript preparation and submission), Coordination & Management (study project management, participant coordination, IRB/Ethics board management, vendor management for labs, test kits, wearables), Operational Excellence (rapid participant recruitment, clinical study workflows, inventory and shipping logistics), and Flexible Approach to Science (RCTs, observational studies, baseline-controlled longitudinal studies, consumer insights).

4Chloe Consumer Health App
CategoryParticipant Mobile Application
Description

The participant-facing mobile application that allows users to enroll in studies, complete e-Consent, log outcomes, sync wearable data, upload photos/videos/PDFs, view personal results, and receive communications for both Chloe Clinical and Chloe LiveLab studies. Distributed via Apple App Store and Google Play, free to participants enrolling in studies.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagship (Early Co-Development Partner)TypeStrategic or Co-development Partner
Description

Announced a partnership on November 1, 2022 to develop virtual clinical trials for alternative medicines, starting with a study on a cannabinoid product for sleep. Study leverages People Science's proprietary CHLOE™ platform and emphasizes a decentralized, home-based research model for cannabis and cannabinoid research aligned with expanding legalization and personalized wellness.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-developed and published a randomized, double-blind, placebo-controlled clinical trial in Nature Scientific Reports (March 2, 2026) evaluating Mimio's novel "fasting mimetic" supplement. The 8-week study of 42 adults with elevated metabolic risk showed statistically significant improvements in cardiometabolic biomarkers (Total Cholesterol, LDL, Oxidized LDL, Fasting Glucose) and 91% improved appetite regulation. The decentralized trial was conducted entirely at participants' homes using People Science's Chloe platform.

Strategic tierFlagship (Chloe Livelab Launch Partner)TypeStrategic or Co-development Partner
Description

Co-launched Chloe LiveLab at SupplySide Global in Las Vegas (announced Nov 4, 2025), a collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. First activation features Phynova's clinically researched Reducose® ingredient for blood glucose management with live CGMs and the Chloe app. Plans to expand the model to additional functional ingredient categories.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Released consumer study findings (May 28, 2026) showing women were six times more likely to report no period cramping after switching from tampons to Saalt's reusable cups and discs. Decentralized study followed 188 participants across three menstrual cycles using the Chloe app; 78% reported overall symptom improvement and 95% would recommend the product. First-of-its-kind U.S. study on reusable menstrual products.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Two multi-study strategic partnership covering the Lp815 GABA probiotic. First, a 7-week decentralized RCT in 83 adults (anxiety) — published in Beneficial Microbes (April 24, 2025). Second, a 9-week decentralized RCT in 139 evaluable adults (sleep) — published in Nature Scientific Reports (Jan 19, 2026). Verb Biotics credits the partnership with enabling market expansion from anxiety into sleep.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Persephone uses Chloe Clinical as the sole software vendor for the ARTEMIS infant synbiotic study (contracted Aug 2024, IRB approval secured independently by Persephone, launched Jan 2025). 136 infants/toddlers aged 2–24 months enrolled; 80% adherence rate. ArtemIS is an IRB-approved RCT exploring tolerability and impact of a proprietary synbiotic (four probiotic strains + HMOs + Vitamin D) on infant/toddler gut microbiome, immune profile, and health outcomes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Digital health platform aggregating wearable and connected-device data (Fitbit, Apple Health, Garmin, Oura, CGMs) for clinical trials and remote patient monitoring. Directly comparable to People Science's wearable integration layer, and an emerging competitor for the evidence-generation workflows People Science sells into consumer health trials.

TypeEmerging player
Description

Software platform for decentralized clinical trials in genomics and rare disease with a participant-facing app and researcher portal. Comparable as a smaller, emerging DCT platform with overlapping technology architecture (mobile app + researcher backend) and a similar go-to-market motion targeting biotech and consumer health sponsors.

TypeRegional player
Description

Microbiome-focused consumer probiotic company that has published clinical trials on its own products in peer-reviewed journals. Comparable to People Science's microbiome/probiotic customer segment (e.g., Verb Biotics), and an adjacent rather than directly competing company that could be a future People Science customer.

TypeDirect peer
Description

Free, open-source electronic data capture platform used by academic and biotech sponsors to build clinical trial databases. Cited explicitly in People Science's Persephone case study as the comparison point Chloe Clinical is positioned against — 'affordable vs alternatives like REDCap' with a consumer mobile UX that REDCap lacks.

TypeDirect peer
Description

Enterprise decentralized clinical trial SaaS platform offering eCOA, eConsent, telehealth, and remote data capture on a unified cloud stack. Directly comparable to Chloe Clinical as a head-to-head DCT platform competitor, with substantially more capital, larger pharma reference customers, and a more mature enterprise sales motion.

TypeBroad incumbent
Description

Largest global CRO with substantial decentralized clinical trial capabilities, technology platforms, and consumer-health evidence services. Competes with People Science for supplement, microbiome, and consumer health evidence-generation work at the enterprise end of the market, with materially more scale and pharma relationships.

TypeDirect peer
Description

Cloud-based EDC and decentralized clinical trial platform with a self-serve SaaS model, electronic data capture, eConsent, and remote monitoring. Competes head-to-head with Chloe Clinical for mid-market and academic trial sponsors, particularly those who want a self-build SaaS alternative to full-service CRO offerings.

TypeBroad incumbent
Description

Enterprise cloud software for life sciences including Veeva Vault EDC, eTMF, and CTMS — the de facto incumbent for clinical trial software at large pharma. Broad incumbent with overlapping clinical operations capabilities, but no consumer-mobile-first or supplement/alternative-medicine focus.

TypeOthers
Description

Vertically integrated supplement and wellness brand with its own clinical research arm, peer-reviewed scientific publications, and direct-to-consumer clinical engagement. Comparable as a customer-type for People Science's services (supplement brand investing in clinical evidence) rather than as a platform competitor.

TypeDirect peer
Description

Decentralized clinical trial platform operating in the same 'metasite' / DCT category as People Science's Chloe. Direct overlap on protocol-driven decentralized trials with consumer mobile apps and integrated wearables. Notable because Science37 was co-founded by People Science's own co-CEO Belinda Tan, making it both a direct competitor and an institutional reference point for the category.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration15 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

People Science

Decentralized Clinical Trial Platformpeoplescience.health

People Science firmographics

Firmographics
Name
People Science
Legal name
PEOPLE SCIENCE, INC.
Website
https://peoplescience.health
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

People Science industry classification

Industry
Product category
Decentralized Clinical Trial Platform
NAICS
Software Publishers (5132), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Decentralized clinical trials
  • Clinical research platform
  • Nutraceutical research
  • Wearable health data
  • Alternative medicine trials

Where People Science is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

People Science business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Chloe Clinical SaaS subscriptions: Software-as-a-Service licensing of the Chloe Clinical platform to enterprise customers (e.g., Persephone Biosciences). Recurring SaaS revenue from customers using Chloe as the sole software vendor for their decentralized clinical trials.
  2. Clinical Research Services (full-service / professional services): Fee-for-service clinical research support including principal investigators, protocol design/consultation, data analysis, manuscript preparation and submission, study project management, participant coordination, IRB/ethics board management, vendor management (labs, test kits, wearables), rapid participant recruitment, and inventory/shipping logistics. Engagements appear to be project-based contracts for individual studies.
  3. Chloe LiveLab collaborative research partnerships: Collaborative ingredient-brand research model with ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. Revenue model is partnership-driven, enabling joint promotional and evidence-generation activities (e.g., Phynova's Reducose® activation).

Pricing tiers

ModelBillingPrice
SubscriptionAnnualChloe Clinical SaaS — quote-based subscription
OtherMulti-year contractFull-service Clinical Research Services — custom project-based
FreemiumPay-as-you-goChloe Consumer Health app for participants — free

Go-to-market motion4 records

Distribution channels5 records

Marketing channels10 records

People Science product offering

Product offering

Core offering

People Science operates a proprietary technology platform called CHLOE (Consumer Health Learning & Organizing Ecosystem) that powers decentralized clinical trials for consumer health, dietary supplement, cannabis, microbiome, and women's health brands. The offering combines a participant-facing mobile app, a researcher/admin web portal, and a clinical operations SaaS backend with integrated wearables, home biomarker collection, and HIPAA/GDPR-compliant data handling. The company wraps this software stack with optional full-service clinical research services (principal investigators, protocol design, IRB management, recruitment, data analysis, manuscript preparation), so customers can buy SaaS-only self-build, full-service execution, or a hybrid — evidenced by named engagements with Persephone Biosciences (SaaS-only ARTEMIS trial), Mimio, Verb Biotics, Life Extension, Phylos, Saalt, and Sip2Sleep.

Product overview

People Science offers a unified clinical research platform — the CHLOE (Consumer Health Learning & Organizing Ecosystem) — delivered as a portfolio of coordinated modules rather than a single monolithic product. At the core sits Chloe Clinical, the decentralized clinical trial SaaS used to design and run protocol-driven research at scale with fully customizable forms, e-consent, wearables integration, and bio specimen collection. Layered on top is Chloe LiveLab, a collaborative ingredient-brand research model that turns randomized controlled trial designs into consumer-facing real-world evidence experiences. The participant-facing Chloe App ties the platform together, enabling enrollment, data entry, wearable sync, and results delivery. People Science also wraps these software modules with Clinical Research Services covering protocol design, IRB management, recruitment, data analysis, and manuscript preparation, so clients can engage at any level from SaaS-only self-build (as Persephone Biosciences did for the ARTEMIS trial) through full-service execution.

Differentiator

Problem solved

Functional benefit

Brands

  • Chloe Clinical: A decentralized clinical trial software-as-a-service platform that supports protocol-driven research with a customizable mobile app, wearables integration, bio-specimen collection, and HIPAA-compliant infrastructure.
  • Chloe LiveLab
  • Chloe

Products and services

  • Chloe Clinical A decentralized clinical trial software-as-a-service platform that enables protocol-driven research at any scale. Fully customizable, with high-quality data collection from an engaging participant mobile app, objective data collection through wearables integration (Oura, Garmin, Fitbit, Apple Watch, CGMs, smart scales) and bio specimen collections (blood, saliva, stool, urine, vaginal swabs), and HIPAA-compliant enterprise-grade security. Used by biotech sponsors (e.g., Persephone Biosciences ran the ARTEMIS infant synbiotic trial on it as sole software vendor) and supplement/cannabis brands for RCTs.
  • Chloe LiveLab A collaborative ingredient-brand research model that collects real-world health data from customers to bolster product claims, enhance participant engagement, identify super-users, and strengthen evidence with objective and subjective data from photos, wearables, and surveys. Targets ingredient suppliers and consumer brands seeking real-world evidence for functional ingredients.
  • Clinical Research Services Full-service research support offered alongside the Chloe platform: Scientific & Decentralized Trial Expertise (Principal Investigators, protocol design or consultation, data analysis, manuscript preparation and submission), Coordination & Management (study project management, participant coordination, IRB/Ethics board management, vendor management for labs, test kits, wearables), Operational Excellence (rapid participant recruitment, clinical study workflows, inventory and shipping logistics), and Flexible Approach to Science (RCTs, observational studies, baseline-controlled longitudinal studies, consumer insights).
  • Chloe Consumer Health App The participant-facing mobile application that allows users to enroll in studies, complete e-Consent, log outcomes, sync wearable data, upload photos/videos/PDFs, view personal results, and receive communications for both Chloe Clinical and Chloe LiveLab studies. Distributed via Apple App Store and Google Play, free to participants enrolling in studies.

Companies that use People Science

Customer profile

Named customers11 records

Segments6 records

Ideal customer profiles1 record

People Science technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability5 records

Feature7 records

People Science partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship (early co-development partner), flagship, flagship (chloe livelab launch partner) and major.

  • Woven Scienceflagship (early co-development partner)Strategic or Co-development PartnerAnnounced a partnership on November 1, 2022 to develop virtual clinical trials for alternative medicines, starting with a study on a cannabinoid product for sleep. Study leverages People Science's proprietary CHLOE™ platform and emphasizes a decentralized, home-based research model for cannabis and cannabinoid research aligned with expanding legalization and personalized wellness.
  • Mimio HealthflagshipStrategic or Co-development PartnerCo-developed and published a randomized, double-blind, placebo-controlled clinical trial in Nature Scientific Reports (March 2, 2026) evaluating Mimio's novel "fasting mimetic" supplement. The 8-week study of 42 adults with elevated metabolic risk showed statistically significant improvements in cardiometabolic biomarkers (Total Cholesterol, LDL, Oxidized LDL, Fasting Glucose) and 91% improved appetite regulation. The decentralized trial was conducted entirely at participants' homes using People Science's Chloe platform.
  • Phynovaflagship (chloe livelab launch partner)Strategic or Co-development PartnerCo-launched Chloe LiveLab at SupplySide Global in Las Vegas (announced Nov 4, 2025), a collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. First activation features Phynova's clinically researched Reducose® ingredient for blood glucose management with live CGMs and the Chloe app. Plans to expand the model to additional functional ingredient categories.
  • SaaltmajorStrategic or Co-development PartnerReleased consumer study findings (May 28, 2026) showing women were six times more likely to report no period cramping after switching from tampons to Saalt's reusable cups and discs. Decentralized study followed 188 participants across three menstrual cycles using the Chloe app; 78% reported overall symptom improvement and 95% would recommend the product. First-of-its-kind U.S. study on reusable menstrual products.
  • Verb BioticsflagshipStrategic or Co-development PartnerTwo multi-study strategic partnership covering the Lp815 GABA probiotic. First, a 7-week decentralized RCT in 83 adults (anxiety) — published in Beneficial Microbes (April 24, 2025). Second, a 9-week decentralized RCT in 139 evaluable adults (sleep) — published in Nature Scientific Reports (Jan 19, 2026). Verb Biotics credits the partnership with enabling market expansion from anxiety into sleep.
  • Persephone BiosciencesflagshipStrategic or Co-development PartnerPersephone uses Chloe Clinical as the sole software vendor for the ARTEMIS infant synbiotic study (contracted Aug 2024, IRB approval secured independently by Persephone, launched Jan 2025). 136 infants/toddlers aged 2–24 months enrolled; 80% adherence rate. ArtemIS is an IRB-approved RCT exploring tolerability and impact of a proprietary synbiotic (four probiotic strains + HMOs + Vitamin D) on infant/toddler gut microbiome, immune profile, and health outcomes.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

People Science competitors and assessment

Company assessment

Emerging players

  • Validic: Digital health platform aggregating wearable and connected-device data (Fitbit, Apple Health, Garmin, Oura, CGMs) for clinical trials and remote patient monitoring. Directly comparable to People Science's wearable integration layer, and an emerging competitor for the evidence-generation workflows People Science sells into consumer health trials.
  • Sano Genetics: Software platform for decentralized clinical trials in genomics and rare disease with a participant-facing app and researcher portal. Comparable as a smaller, emerging DCT platform with overlapping technology architecture (mobile app + researcher backend) and a similar go-to-market motion targeting biotech and consumer health sponsors.

Regional players

  • Seed Health: Microbiome-focused consumer probiotic company that has published clinical trials on its own products in peer-reviewed journals. Comparable to People Science's microbiome/probiotic customer segment (e.g., Verb Biotics), and an adjacent rather than directly competing company that could be a future People Science customer.

Direct peers

  • REDCap: Free, open-source electronic data capture platform used by academic and biotech sponsors to build clinical trial databases. Cited explicitly in People Science's Persephone case study as the comparison point Chloe Clinical is positioned against — 'affordable vs alternatives like REDCap' with a consumer mobile UX that REDCap lacks.
  • Medable: Enterprise decentralized clinical trial SaaS platform offering eCOA, eConsent, telehealth, and remote data capture on a unified cloud stack. Directly comparable to Chloe Clinical as a head-to-head DCT platform competitor, with substantially more capital, larger pharma reference customers, and a more mature enterprise sales motion.
  • Castor: Cloud-based EDC and decentralized clinical trial platform with a self-serve SaaS model, electronic data capture, eConsent, and remote monitoring. Competes head-to-head with Chloe Clinical for mid-market and academic trial sponsors, particularly those who want a self-build SaaS alternative to full-service CRO offerings.
  • Science37: Decentralized clinical trial platform operating in the same 'metasite' / DCT category as People Science's Chloe. Direct overlap on protocol-driven decentralized trials with consumer mobile apps and integrated wearables. Notable because Science37 was co-founded by People Science's own co-CEO Belinda Tan, making it both a direct competitor and an institutional reference point for the category.

Broad incumbents

  • IQVIA: Largest global CRO with substantial decentralized clinical trial capabilities, technology platforms, and consumer-health evidence services. Competes with People Science for supplement, microbiome, and consumer health evidence-generation work at the enterprise end of the market, with materially more scale and pharma relationships.
  • Veeva Systems: Enterprise cloud software for life sciences including Veeva Vault EDC, eTMF, and CTMS — the de facto incumbent for clinical trial software at large pharma. Broad incumbent with overlapping clinical operations capabilities, but no consumer-mobile-first or supplement/alternative-medicine focus.

Others

  • Thorne: Vertically integrated supplement and wellness brand with its own clinical research arm, peer-reviewed scientific publications, and direct-to-consumer clinical engagement. Comparable as a customer-type for People Science's services (supplement brand investing in clinical evidence) rather than as a platform competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

People Science social profiles

Digital presence

People Science compliance and trust

Trust signal

Compliance4 records

People Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

People Science leadership team

Management profile

Number of profiles

Profiles3 records

People Science funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

People Science M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about People Science

What does People Science do?

People Science operates a proprietary technology platform called CHLOE (Consumer Health Learning & Organizing Ecosystem) that powers decentralized clinical trials for consumer health, dietary supplement, cannabis, microbiome, and women's health brands. The offering combines a participant-facing mobile app, a researcher/admin web portal, and a clinical operations SaaS backend with integrated wearables, home biomarker collection, and HIPAA/GDPR-compliant data handling. The company wraps this software stack with optional full-service clinical research services (principal investigators, protocol design, IRB management, recruitment, data analysis, manuscript preparation), so customers can buy SaaS-only self-build, full-service execution, or a hybrid — evidenced by named engagements with Persephone Biosciences (SaaS-only ARTEMIS trial), Mimio, Verb Biotics, Life Extension, Phylos, Saalt, and Sip2Sleep.

Is People Science a public or private company?

People Science is a private company. It is classified as venture growth investor backed and is currently operating.

When was People Science founded?

People Science was founded in 2019. It employs 11 to 50 people.

Where is People Science based?

People Science is headquartered in Los Angeles, United States, in the North America region.

How does People Science make money?

Three revenue lines are on record. Chloe Clinical SaaS subscriptions are the primary driver. The others are clinical Research Services (full-service / professional services) and chloe LiveLab collaborative research partnerships.

Who are People Science's main competitors?

Emerging players on record are Validic and Sano Genetics. Seed Health is listed as a regional player. Direct peers are REDCap, Medable, Castor and Science37. Broad incumbents are IQVIA and Veeva Systems. Thorne is listed as an others.

Does People Science have an API?

No public API is recorded for People Science.

What industry is People Science in?

People Science's product category is Decentralized Clinical Trial Platform. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireVeteran-Founded Temple Massager Shows How Mission-Driven Small Brands Can Build Clinical EvidenceA veteran-founded company ran a four-week remote study of 35 women using the Temple Massager, finding anxiety scores fell from 9.91 to 5.11 and fewer headache days. The study, conducted on the People Science platform, showed improvements across seven quality-of-life domains with no adverse events. The company plans to share results with employers and health systems.PR NewswireNew Study Shows Women Were 6x More Likely to Report No Cramping While Using Cups and Discs vs. TamponsSaalt and People Science released a consumer study findings showing women were six times more likely to report zero period cramping after switching from tampons to Saalt's reusable cups and discs, compared to a 4% baseline. The decentralized study followed 188 participants across three menstrual cycles using the Chloe app, with 78% reporting overall symptom improvement and 95% saying they would recommend the product. The findings arrive amid growing consumer skepticism of mainstream menstrual products following recent studies detecting heavy metals and chemical contaminants in tampons.PR NewswireDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic HealthPeople Science and Mimio Health announced the publication of a randomized, double-blind, placebo-controlled clinical trial in Nature Scientific Reports evaluating a novel supplement formulation designed to activate fasting-associated biological pathways. The eight-week study of 42 adults with elevated metabolic risk showed statistically significant improvements in cardiometabolic biomarkers including Total Cholesterol, LDL, Oxidized LDL, and Fasting Glucose, with 91% of participants in the active group reporting improved appetite regulation. The decentralized trial was conducted entirely in participants' homes using People Science's Chloe platform, demonstrating that rigorous clinical research can be conducted outside traditional research settings.MorningstarDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic HealthPeople Science and Mimio Health published results of a randomized, double-blind, placebo-controlled clinical trial in Nature Scientific Reports demonstrating that their novel "fasting mimetic" daily supplement formulation produced statistically significant improvements in cardiometabolic biomarkers including Total Cholesterol, LDL, Oxidized LDL, and Fasting Glucose over eight weeks. The decentralized trial enrolled 42 adults aged 62 with elevated metabolic risk and demonstrated 91% of participants reported improved appetite regulation compared to 47% in the placebo group. The findings establish a clinically validated foundation for future metabolic research and suggest targeted nutritional interventions can engage fasting-associated biology without dietary restriction.SupplysidesjSupplement industry roundup: Research to retailThe article reports on developments in the supplement and nutraceutical industry including a collaboration between People Science and Phynova to launch Chloe LiveLab for research, a partnership between ADM and the University of Oxford for a clinical trial on probiotics and gut microbiome, and new supplement product launches by Pinkmatter, Elevate Organic, and Lemme. It covers scientific reviews of ingredients like EGCG, L-citrulline, and L-theanine, along with branding updates from Anresco Labs, NJ Labs, Gnosis by Lesaffre, and Herbs, Etc.MorningstarPeople Science and Phynova Launch Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model to Generate Real-World EvidencePeople Science and Phynova launched Chloe LiveLab at SupplySide Global, a model for real-world evidence generation. The first activation featured Reducose with consumers wearing CGMs to visualize glucose responses. The company plans to expand the model into additional functional ingredient categories.PR NewswirePeople Science and Phynova Launch Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model to Generate Real-World EvidencePeople Science and Phynova launched Chloe LiveLab at SupplySide Global in Las Vegas on November 4, 2025, a new collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through open-label studies deployed via the Chloe platform and app. The first LiveLab activation features Reducose, Phynova's clinically researched natural ingredient for blood glucose management, with live demonstrations showing how consumer health brand leaders used continuous glucose monitors to visualize their own glucose responses. The platform converts validated randomized controlled trial designs into consumer-facing studies, providing data-driven support for brand partners while offering consumers immediate insight into product performance.PR NewswirePhylos® and People Science® Announce Results of IRB-Backed Controlled Research Study on the Energizing Effects of THCVPhylos and People Science announced the results of an IRB-approved clinical study showing that THCV-dominant cannabis extracts significantly increased energy, activity, and well-being while reducing fatigue compared to placebo. Concurrently, Phylos launched its Natural Natural™ ingredient brand to commercialize these rare cannabinoid genetics across various wholesale partners in the United States and Canada.FinSMEsPeople Science Raises $5.3M in Second Seed FundingPeople Science, a Los Angeles-based scientific research company, raised $5.3 million in second seed funding led by Acre Venture Partners, bringing its total seed investment to $8.5 million. The company plans to utilize the capital to expand its CHLOE technology platform and support client growth for its software licensing services.